Chicago, Illinois — According to state and local economic development sources Evozyne plans to invest $3,375,000.00 to build out new space in Chicago. The company plans to occupy the new space at 2430 N Halsted St in Chicago, on or about May 1, 2021. According to the company website Evozyne’s data-driven molecular engineering technology computationally accelerates what can be achieved through millions of years of evolution. Our approach is vastly more efficient than directed evolution and more comprehensive than current physics-based design of proteins. At Evozyne, we are passionate about solving problems, from molecular scale to global. Our mission is to unlock the potential of novel proteins to solve complex human and societal challenges by revolutionizing protein design. Our data-driven approach to molecular engineering couples state-of-the-art machine learning and statistical techniques with high throughput gene synthesis and screening technology in a seamless design-build-test cycle.

To learn more about Evozyne, visit http://evozyne.com/

Company Contact:
Rama Ranganathan, Co-founder
https://www.linkedin.com/in/ramaranganathan/
312-847-1350

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved